Literature DB >> 19387830

The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice.

Sebastian P Fernandez1, Michael Nguyen, Tin Thing Yow, Cindy Chu, Graham A R Johnston, Jane R Hanrahan, Mary Chebib.   

Abstract

The consumption of flavonoid-rich foods, in particular fruits and vegetables, has been epidemiologically associated with a reduced risk of heart disease, neurodegenerative disease, cancer and other chronic diseases. Flavonoid glycosides, the main class of flavonoids, have been shown to exert CNS-mediated activities, particularly as sedative-hypnotics, analgesics or both, nevertheless no studies have evaluated these agents in anxiety. This study assessed the potential anxiolytic effect of three flavonoid glycosides, myrcitrin, naringin and gossypin, in the elevated plus maze test (EPM). Myricitrin (1 mg/kg) was effective on the EPM showing a clear anxiolytic effect with no signs of sedation. However, higher doses showed possible sedative and myorelaxation effects. Gossypin and naringin both shared a similar profile, with low doses (1 mg/kg) inducing a robust anxiolytic effect which diminished with increasing doses of the flavonoids. Higher doses of these two flavonoids showed a dramatic increase in the open arm exploration accompanied by a decrease in locomotor activity. Hence, naringin (30 mg/kg) and gossypin (30 mg/kg) induce both anxiolytic and sedative effects. These results suggest that flavonoid glycosides have the potential to exert a range of CNS-mediated biological activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387830     DOI: 10.1007/s11064-009-9969-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

1.  A comparative study of the analgesic and anti-inflammatory activities of pectolinarin isolated from Cirsium subcoriaceum and linarin isolated from Buddleia cordata.

Authors:  M Martínez-Vázquez; T O Ramírez Apan; A L Lastra; R Bye
Journal:  Planta Med       Date:  1998-03       Impact factor: 3.352

Review 2.  Factors controlling measures of anxiety and responses to novelty in the mouse.

Authors:  S E File
Journal:  Behav Brain Res       Date:  2001-11-01       Impact factor: 3.332

3.  A phase II evaluation of flavopiridol as second-line chemotherapy of endometrial carcinoma: a Gynecologic Oncology Group study.

Authors:  Edward C Grendys; John A Blessing; Robert Burger; James Hoffman
Journal:  Gynecol Oncol       Date:  2005-08       Impact factor: 5.482

4.  Antinociceptive interaction between alprazolam and opioids.

Authors:  C G Pick
Journal:  Brain Res Bull       Date:  1997       Impact factor: 4.077

Review 5.  Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data.

Authors:  Mark Messina; Suzanne Ho; D Lee Alekel
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2004-11       Impact factor: 4.294

6.  Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase.

Authors:  A J Day; F J Cañada; J C Díaz; P A Kroon; R Mclauchlan; C B Faulds; G W Plumb; M R Morgan; G Williamson
Journal:  FEBS Lett       Date:  2000-02-25       Impact factor: 4.124

7.  Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats.

Authors:  Mohammad-Reza Zarrindast; Parvin Rostami; Morteza Zarei; Ali Roohbakhsh
Journal:  Basic Clin Pharmacol Toxicol       Date:  2005-11       Impact factor: 4.080

Review 8.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.

Authors:  Claudine Manach; Gary Williamson; Christine Morand; Augustin Scalbert; Christian Rémésy
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

9.  Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans.

Authors:  V D Bokkenheuser; C H Shackleton; J Winter
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

10.  Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.

Authors:  Sebastian P Fernandez; Kenneth N Mewett; Jane R Hanrahan; Mary Chebib; Graham A R Johnston
Journal:  Neuropharmacology       Date:  2008-07-09       Impact factor: 5.250

View more
  22 in total

1.  Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish.

Authors:  Sean M Bugel; Robert L Tanguay
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-27       Impact factor: 4.219

2.  Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q.

Authors:  Tin T Yow; Elena Pera; Nathan Absalom; Marika Heblinski; Graham A R Johnston; Jane R Hanrahan; Mary Chebib
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Protective effect of naringin against ankylosing spondylitis via ossification, inflammation and oxidative stress in mice.

Authors:  Kang Liu; Lianguo Wu; Xiaolin Shi; Fengqing Wu
Journal:  Exp Ther Med       Date:  2016-05-31       Impact factor: 2.447

4.  Anxiolytic-like effect of Shigyakusan extract with low side effects in mice.

Authors:  Machiko Tanaka; Tadaaki Satou; Kazuo Koike
Journal:  J Nat Med       Date:  2013-02-02       Impact factor: 2.343

5.  Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus.

Authors:  Mohit Kwatra; Ashok Jangra; Murli Mishra; Yogita Sharma; Sahabuddin Ahmed; Pinaki Ghosh; Vikas Kumar; Divya Vohora; Razia Khanam
Journal:  Neurochem Res       Date:  2016-05-21       Impact factor: 3.996

6.  Naringin Confers Protection against Psychosocial Defeat Stress-Induced Neurobehavioral Deficits in Mice: Involvement of Glutamic Acid Decarboxylase Isoform-67, Oxido-Nitrergic Stress, and Neuroinflammatory Mechanisms.

Authors:  Olawumi M Oladapo; Benneth Ben-Azu; Abayomi Mayowa Ajayi; Osagie Emokpae; Aya-Ebi Okubo Eneni; Itivere Adrian Omogbiya; Ezekiel O Iwalewa
Journal:  J Mol Neurosci       Date:  2020-08-07       Impact factor: 3.444

7.  Feature-Based Molecular Network-Guided Dereplication of Natural Bioactive Products from Leaves of Stryphnodendron pulcherrimum (Willd.) Hochr.

Authors:  Paulo Gomes; Luis Quirós-Guerrero; Consuelo Silva; Sônia Pamplona; Jean A Boutin; Marcos Eberlin; Jean-Luc Wolfender; Milton Silva
Journal:  Metabolites       Date:  2021-04-29

Review 8.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

9.  Estrogens of multiple classes and their role in mental health disease mechanisms.

Authors:  Cheryl S Watson; Rebecca A Alyea; Kathryn A Cunningham; Yow-Jiun Jeng
Journal:  Int J Womens Health       Date:  2010-08-09

10.  Pharmacological Blockade of PPARα Exacerbates Inflammatory Pain-Related Impairment of Spatial Memory in Rats.

Authors:  Jessica C Gaspar; Catherine Healy; Mehnaz I Ferdousi; Michelle Roche; David P Finn
Journal:  Biomedicines       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.